USPTO 2015–2025 USPTO PatentsView Foreign Corporation

OUR United Corporation

USPTO PatentsView assignee record — 82 granted patents across 17 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

82
Total patents granted
17
CPC technology areas
15.4
Avg claims per patent
5-year filing velocity

The verdict

OUR holds 82 US patents across 17 technology areas — rank #4,347 of 50,000 tracked assignees.

#4,347
of 50,000 US assignees by volume
Top 7%
by Innovation Score (55.4/100)
15.4
avg claims per patent

Portfolio overview

OUR UNITED CORPORATION has been granted 82 US utility patents between 2020 and 2025, placing OUR UNITED CORPORATION at rank #4,347 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.4 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, OUR UNITED CORPORATION is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 55.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 82 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. OUR UNITED CORPORATION's 15.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark OUR UNITED CORPORATION against peers pursuing similar technology classes.

How does OUR compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows OUR holds 82 patents — placing it at rank #4,347 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

OUR's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

010203040 202020212022202320242025 13
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
OUR UNITED CORPORATION patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 6 7.3%
2021 14 17.1%
2022 12 14.6%
2023 8 9.8%
2024 29 35.4%
2025 13 15.9%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard

Where it ranks

Overall rank by patents

#4,347

Across all tracked assignees

Innovation Score

55.4 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does OUR UNITED CORPORATION hold?
OUR UNITED CORPORATION holds 82 US granted patents filed between 2020 and 2025, spanning 17 technology areas.
What is OUR UNITED CORPORATION's Innovation Score?
OUR UNITED CORPORATION has an Innovation Score of 55.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does OUR UNITED CORPORATION focus on?
OUR UNITED CORPORATION's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 65 patents. The company has filed patents in 17 CPC subclasses total.
Is OUR UNITED CORPORATION's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for OUR UNITED CORPORATION.
What does claim depth mean for OUR UNITED CORPORATION's patents?
OUR UNITED CORPORATION's patents average 15.4 claims each. This falls within the standard range, providing solid legal coverage.
How is the OUR UNITED CORPORATION patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

OUR's 82 grants land it in the top 7% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — OUR ranks #4,347 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61N — see who else leads that technology area. A61N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov